Patent №
US 7,312,061
Granted
2007-12-25
Filed 2005
Owner
SCHERING CORPORATION
Lab
—
AI components
1
ml
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
11233581
The present invention relates to crystals of the ERK2 polypeptide and complexes thereof which are useful, inter alia, for structure assisted drug design.
AI classification
Machine learning0.90
Evolutionary computation0.06
Natural language0.01
Planning0.00
AI hardware0.00
Speech0.00
Vision0.00
Knowledge representation0.00
Ownership
SCHERING CORPORATION
assignment · 169620233
Assignors
ENGLISH, JESSIE, FISCHMANN, THIERRY O., HESSON, THOMAS, HRUZA, ALAN W., JIN, WEIHONG, REICHERT, PAUL, SMITH, CATHERINE, TAREMI, SHAHRIAR SHANE
On an employer assignment, the assignors are typically the inventors.
From the same owner
SYSTEM AND METHOD FOR SEGMENTING M-MODE ULTRASOUND IMAGES SHOWING BLOOD VESSEL WALL MOTION OVER TIMEUS 8,861,811 · 2014TREATMENT OF DIABETES USING ANTIBODIES TO IL-23, IL-23 RECEPTOR AND IL-17US 7,820,168 · 2010X-RAY ARRANGEMENT AND X-RAY CONTRAST PROCESS FOR IMAGING AN OBJECT UNDER EXAMINATION THAT CONTAINS AT LEAST ONE RADIOPAQUE ELEMENT AS WELL AS USE OF THE X-RAY ARRANGEMENTUS 7,672,431 · 2010PEPTIDE VIRAL ENTRY INHIBITORSUS 7,592,315 · 2009PROCESS FOR THE PRODUCTION OF DENDRITIC TRIMESIC ACID TRIAMIDESUS 7,199,268 · 2007METHOD FOR PRODUCING AND SCREENING MASS-CODED COMBINATORIAL LIBRARIES FOR DRUG DISCOVERY AND TARGET VALIDATIONUS 7,169,563 · 2007ADENOSINE RECEPTORUS 7,157,244 · 2007SYNTHESIS OF TEMOZOLOMIDE AND ANALOGSUS 7,087,751 · 2006